Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Endocrine System Diseases × fluorodopa F 18 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 2 Recurrence 1 Pheochromocytoma 1 Insulinoma 1 Hypoglycemia 1 Hyperinsulinism 1 Glioblastoma 1 Endocrine System Diseases 1 Congenital Hyperinsulinism 1

Interventions

relacorilant 1 pembrolizumab 1 parathyroid hormone-related peptide (1-36) 1 niraparib 1 fluorodopa F 18 1 Parathyroid Hormone-Related Protein 1 Parathyroid Hormone 1 6-fluorodopamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004847 2026-03-30

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting

Endocrine System Diseases, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡